Skip to main content

Omicron

 Rise of the Omicron Virus
    
    As the number of vaccinated individuals continue to increase each day, the long-lasting COVID-19 pandemic comes closer to nearing an end. However, things seemed to take an unexpected turn when the World Health Organization designated the new SARS-CoV-2 variant, B.1.1.529, or Omicron, as a variant of concern for its large number of mutations which can lead to increased infection and escape from immunity. The first known confirmed Omicron sample was collected in South Africa on November 9 2021. There have been many other coronavirus mutations but what worries researchers most is Omicron’s rapid rise in South Africa, which suggests the variant could result in an explosive increase in COVID-19 cases worldwide. On December 1, 2021, there have been 8,561 recorded Omicron cases in South Africa. As of December 4, the Omicron variant has spread to over 40 countries and territories, including the United States where it was first detected in California. So, what makes Omicron a variant of concern? Will the current vaccines be effective against Omicron? Will Omicron lead to new round of lock down?

Omicron Mutations

    The Omicron variant has a total of 60 mutations compared to the original Wuhan variant. Of these mutations, 32 affect the spike protein and many of these mutations are located in a region that recognizes receptors on human cells. The large number of mutations may reduce immunity in people who were previously infected and in vaccinated individuals. Anthony Fauci of the National Institute of Allergy and Infectious Diseases says that "the mutations seen in Omicron and in other variants suggest that they are associated with increased infectivity." Other than a speculated increased infection rate, very little is known about the effects of these mutations. Scientists are in the process of measuring the ability of neutralizing antibodies triggered by previous infections and vaccinations to stop Omicron from infecting cells.    

Vaccinations and Infection Severity

There have been reports of breakthrough infections involving the Omicron variant in COVID-19 vaccinated individuals (including the first Omicron case in the U.S.) So, are current vaccines less effective in preventing infection by the Omicron variant than other variants? Scientists say it's not yet clear how effective the vaccines will be against the omicron. Immunity studies suggest that modest levels of neutralizing antibodies may protect people from severe forms of COVID-19. Paul Bieniasz, a virologist at Rockefeller University in New York City, advocates for a booster shot in light of the new Omicron virus saying that "third doses supercharge neutralizing-antibody levels, and it’s likely that this will provide a bulwark against Omicron’s ability to evade these antibodies. Other aspects of the immune system, particularly T cells, may be less affected by Omicron’s mutations than antibody responses.

Although it's still too early to come to a conclusion about the severity of COVID-19 disease caused by the Omicron variant, Fauci, in reference to data from South Africa, stated that "it appears with the cases that are seen, we are not seeing a very severe profile of the disease." However, severity, hospitalization, and death are lagging indicators so it will take at least several more weeks before any definitive conclusions can be made about the severity of the variant.

Conclusion

     The variant's large number of mutations are concerning to scientists and preliminary evidence suggests an increased risk of reinfection with Omicron but a possibly less severe disease profile. In spite of all the recent data, Omicron is still a very new and under researched topic. As time goes on and more data becomes available, more reliable information can be determined on the variant. For now, it's important that people continue following safety precautions especially with this new and relatively unknown variant circulating the globe. Finally, with data suggesting that the Omicron variant has increased infectivity, it's more important than ever to get vaccinated and also consider a booster shot.

Sources

1. Callaway, Ewen, and Heidi Ledford. “How Bad Is Omicron? What Scientists Know so Far.” Nature News, Nature Publishing Group, 2 Dec. 2021, https://www.nature.com/articles/d41586-021-03614-z.

2. “Classification of Omicron (B.1.1.529): SARS-COV-2 Variant of Concern.” World Health Organization, World Health Organization, https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.

3. Upright, Ed, and Melissa Macaya. “December 7, 2021 Omicron Variant Latest Global News Updates.” CNN, Cable News Network, 8 Dec. 2021, https://www.cnn.com/world/live-news/omicron-coronavirus-variant-12-07-21-intl/index.html.

Comments

Popular posts from this blog

Efficacy of Masks

Do Wearing Masks Really Prevent Coronavirus            For weeks, U.S. health authorities discouraged healthy Americans from wearing masks, believing they would do more harm than good. However, other countries such as China and South Korea have required all citizens to wear a mask when entering a public setting to prevent the spread of the coronavirus. But really how effective are these masks against the coronavirus? On April 3rd, Nature Medicine published an article describing their findings based off an experiment testing the efficacy of surgical face masks against coronavirus, influenza virus and rhinovirus.   Study Findings      Their results demonstrated that surgical masks were largely effective in reducing coronavirus transmission through respiratory droplets as well as aerosol particles. 3/10 people who did not wear a mask were infected with the coronavirus through droplet particles. Out of 11 people who wore masks, not a single one was infected through the transmission

Breakthrough Infections

 COVID-19 Breakthrough Infections     As of August 2021, a little over 50% of the U.S. population has been fully vaccinated against COVID-19. However, despite the increasing number of vaccinated individuals and high efficacy of the vaccines, rare breakthrough cases have occurred. With the reports of breakthrough cases, or instances when people who are fully vaccinated get infected with COVID-19, many questions have arisen. How common are breakthrough infections? What are the symptoms? How severe are the cases? These questions are addressed in a peer-reviewed study investigating breakthrough cases among healthcare workers in Israel. The study was recently published in the New England Journal of Medicine on July 28, 2021.  About the Study     The study setting took place in the Sheba Medical Center, which is the largest medical center in Israel staffed with 12,586 healthcare workers. By April 28, 2021, 11,453 workers (91%) had been fully vaccinated with the Pfizer vaccine. The study was

Plasma for COVID-19 treatment

FDA Authorizes Plasma for COVID-19 Treatment                     COVID-19, which has been spreading across the globe since March, has affected the lives of Americans for over six months. Many people, including the President, are eager to eliminate the virus after a dreadful 6 months of rising cases and quarantine. To their dismay, hopes of eliminating the virus by Easter and then by August, seemed to turn into an unreachable dream for Americans. With cases rising and no sure vaccine or treatment for the virus, a future without COVID-19 seemed further and further away. Yet, this Sunday on August 23, 2020, the U.S. Food and Drug Administration authorized the first treatment for COVID-19: convalescent plasma. While the plasma has only been authorized for emergency use, many people see this authorization as progress towards eliminating the virus. However, others believe that the plasma is not as effective, and that the FDA was pressured by Trump to authorize treatment for COVID-19 to provi